by Henry L.T. Chen, Frank Schoneveld and Alex An

Recently,China’s National Development and Reform Commission (NDRC) imposed large fines on two pharmaceutical distributors.  This move indicates the enforcement agency, which supervises price-related monopolistic practices, is beginning to take a more active role in enforcing the country’s Anti-Monopoly Law.

To read the full article, click here